Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04181203
Title Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy (CARLHA-2)
Acronym CARLHA-2
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors UNICANCER
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.